COL3A1 and Ehlers-Danlos syndrome: Genetic examination revealed a glycine substitution in the COL3A1 gene in almost two-thirds (63%) of the index patients, which corresponds with the current literature1,5 and the Ehlers-Danlos Syndrome Variant Database (https://databases.lovd.nl/shared/variants/COL3A1).